2014The Practical Journal of CancerRequires access

Application Value of Aztreonam in Lower Respiratory Tract Infection of Cancer Patients

LI Xue-lia

Open publisher page 0 citations

Abstract

Objective To study application value of Aztreonam in lower respiratory tract infection of cancer patients.Methods 340 cases of lower respiratory tract infection in cancer patients were divided into 2 groups. The observation group were treated with astronomy,the control group received ceftazidime,and clinical efficacy of the 2 groups were compared. Results The effective rate and bacterial clearance rate in the observation group were 87. 06% and 92. 54%; the effective rate and bacterial clearance rate in the control group were 83. 35% and 86. 76%. Bacterial clearance rate between the 2 groups had statistical difference( P 0. 05). The effective rate and bacterial clearance rate in the observation group were better than those of the control group,but the economic cost of the control group was less than that of the observation group. Conclusion Aztreonam has significant clinical effects for cancer combined with lower respiratory tract infection,and it is worthy of clinical application.

About this research paper

What this paper is about

Objective To study application value of Aztreonam in lower respiratory tract infection of cancer patients.Methods 340 cases of lower respiratory tract infection in cancer patients were divided into 2 groups. The observation group were treated with astronomy,the control group received ceftazidime,and clinical efficacy of the 2 groups were compared. Results The effective rate and bacterial clearance rate in the observation group were 87. 06% and 92. 54%; the effective rate and bacterial clearance rate in the control group were 83. 35% and 86. 76%. Bacterial clearance rate between the 2 groups had statistical difference( P 0. 05). The effective rate and bacterial clearance rate in the observation group were better than those of the control group,but the economic cost of the control group was less than that of the observation group. Conclusion Aztreonam has significant clinical effects for cancer combined with lower respiratory tract infection,and it is worthy of clinical application.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study application value of Aztreonam in lower respiratory tract infection of cancer patients.Methods 340 cases of lower respiratory tract infection in cancer patients were divided into 2 groups. The observation group were treated with astronomy,the control group received ceftazidime,and clinical efficacy of the 2 groups were compared. Results The effective rate and bacterial clearance rate in the observation group were 87. 06% and 92. 54%; the effective rate and bacterial clearance rate in the control group were 83. 35% and 86. 76%. Bacterial clearance rate between the 2 groups had statistical difference( P 0. 05). The effective rate and bacterial clearance rate in the observation group were better than those of the control group,but the economic cost of the control group was less than that of the observation group. Conclusion Aztreonam has significant clinical effects for cancer combined with lower respiratory tract infection,and it is worthy of clinical application.

Key concepts: Aztreonam, Medicine, Lower respiratory tract infection, Respiratory tract, Internal medicine, Ceftazidime, Respiratory tract infections, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source